Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients

The presence and degree of peripheral blood involvement in patients with cutaneous T-cell lymphoma (CTCL) portend a worse clinical outcome. Available systemic therapies for CTCL may variably decrease tumor burden and improve quality of life, but offer limited effects on survival; thus, novel approac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Principais autores: Cyrenne, Benoit M., Lewis, Julia M., Weed, Jason G., Carlson, Kacie R., Mirza, Fatima N., Foss, Francine M., Girardi, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680613/
https://ncbi.nlm.nih.gov/pubmed/28972015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-06-792150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados